Marken James G. 4
4 · ANI PHARMACEUTICALS INC · Filed Jun 11, 2024
Insider Transaction Report
Form 4
Marken James G.
Vice President, Operations
Transactions
- Exercise/Conversion
Common Stock
2024-06-07$49.51/sh+7,250$358,948→ 123,616 total - Exercise/Conversion
Stock Option (right to buy)
2024-06-07$49.51/sh−7,250$358,948→ 0 totalExercise: $49.51Exp: 2027-03-30→ Common Stock (7,250 underlying) - Tax Payment
Common Stock
2024-06-07$67.70/sh−11,087$750,590→ 117,829 total - Exercise/Conversion
Stock Option (right to buy)
2024-06-07$57.06/sh−5,300$302,418→ 0 totalExercise: $57.06Exp: 2028-04-05→ Common Stock (5,300 underlying) - Exercise/Conversion
Common Stock
2024-06-07$57.06/sh+5,300$302,418→ 128,916 total
Footnotes (4)
- [F1]The number of shares beneficially owned by the reporting person is amended in this Form 4 to correct an administrative error in a Form 4 filed on March 9, 2023, which misreported that 1,951 shares were withheld on March 7, 2023 to cover taxes on a vesting of shares on that date, when 1,591 shares were withheld. In correcting this administrative error, the number of shares beneficially owned by the reporting person reflects an increase of 360 shares.
- [F2]The shares were sold in multiple trades at prices ranging from $67.64 to $68.10. The price reported above reflects the weighted average sales price.
- [F3]25% of the total options vested on each of March 31, 2018, March 31, 2019, March 31, 2020, and March 31, 2021.
- [F4]25% of the total options vested on each of April 6, 2019, April 6, 2020, April 6, 2021, and April 6, 2022.